Question 1

Does Blackstone own CBIO stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Blackstone holds 62,647 shares of CBIO (Crescent Biopharma), worth $1.1M.

Question 2

How many shares of CBIO does Blackstone own?

Accepted Answer

As of its Q2 2026 13F, Blackstone holds 62,647 shares of CBIO (Crescent Biopharma).

Question 3

What is Blackstone's CBIO position worth?

Accepted Answer

As of its Q2 2026 13F, Blackstone's CBIO position is worth $1.1M.

Question 4

Is Blackstone buying or selling CBIO?

Accepted Answer

In Q2 2026, Blackstone opened a new CBIO position of 62,647 shares.

Question 5

When did Blackstone first buy CBIO?

Accepted Answer

Blackstone first reported CBIO in its Q2 2025 13F and has listed it in 4 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	New	62,647	-	$1.1M	0.0%	$18.00	35
2026-Q1	Exited	0	-100.0%	$0	0.0%	$11.19	0
2025-Q4	Unchanged	75,614	0.0%	$896,782	0.0%	$11.60	0
2025-Q3	Unchanged	75,614	0.0%	$899,050	0.0%	$12.29	0
2025-Q2	New	75,614	-	$1.2M	0.0%	$15.90	35

CBIO5 quarters

CBIO
5 quarters